| Parameter | n=22 |
|---|---|
| Median age in years (range) | 27 (21-32.5) |
| Gender (Male: Female) | 4:18 |
| Median duration of symptoms in months (range) | 8 (1-60) |
| Median age of onset in years (range) | 26.5 (15-49) |
| Median ESR in mm/1st hour (range) | 32 (15.75-51.25) |
| Median CRP in mg/dl (range) | 6.8 (3.4-22.03) |
| Median ITAS (range) | 7 (4-14.25) |
| Median DEI.Tak (range) | 7.5 (4-13.25) |
| Medications Used |
n (%) |
| Treatment naïve |
14 (63.64%) |
| Second line Immunosuppression ((MMF =6) and Immunomodulation (MTX=1) along with steroids (n=7) |
7 (31.82%) |
| Biological DMARDs |
Nil |